Bile duct stents: Is there an increased rate of complications in patients receiving chemotherapy?

Lofts, F.; Evans, T.R. Jeffry; Mansi, Janine; Glees, J.P.; Knight, M. J.

doi:10.1016/s0959-8049(96)00365-6

Cited by 21 publications

(18 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Lofts et al 15 reported the safety of chemotherapy with biliary stent placement, although the primary tumors were heterogeneous, the chemotherapeutic regimens used in their study were all 5-fluorouracil (5-FU)Ybased, and EMS was used in only a small proportion of patients. As reported recently, 16,17 EMS placement in resectable pancreatic cancer patients receiving neoadjuvant chemoradiation did not increase perioperative morbidity or mortality.…”

Section: Discussionmentioning

confidence: 99%

Efficacy and Safety of Metallic Stents in Patients With Unresectable Pancreatic Cancer Receiving Gemcitabine

Nakai

Isayama²,

Kawabe³

et al. 2008

Pancreas

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Efficacy and Safety of Metallic Stents in Patients With Unresectable Pancreatic Cancer Receiving Gemcitabine

Nakai

Isayama²,

Kawabe³

et al. 2008

Pancreas

View full text Add to dashboard Cite

show abstract

“…Other literatures also conform that patients' mortality who receiving internal-external drainage significantly higher than the external drainage or biliary stenting treatment (Ho et al, 2013;Lofts et al, 1997;Manwong et al, 2013). But the internal-external drainage has no related to be beneficial for the physiological drainage and could achieve good prognosis as we previous thought.…”

Section: Discussionmentioning

confidence: 73%

Internal-External Percutaneous Transhepatic Biliary Drainage for Patients with Malignant Obstructive Jaundice

Xu¹,

Lv²,

Huang³

et al. 2014

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Asian Pac J Cancer Prev, 15 (21), 9391-9394 IntroductionPercutaneous transhepatic biliary drainage is becoming more and more useful as a palliative treatment for patients with malignant obstructive jaundice, which could not only significantly reduce bilirubin levels, improve liver function and prolong survival time, but also be used as a preoperative drainage, provide the conditions for subsequent treatment (Boursier et al., 2009;Herzog et al., 2012;Kaya et al., 2012;Zhu et al., 2012). In our center, if the guide wire could pass through the occlusion and into the duodenum, we prefer to use internal-external drainage, while the occlusion is not crossed, external drainage biliary catheter is placed. We think that internal-external drainage in the treatment of malignant obstructive jaundice not only could lead bile flow into intestine, maintain the physical channel of bile drainage, also decline bilirubin level quickly which is beneficial to the recovery of liver function and reduce the gastrointestinal complications caused by lack of bile. In order to evaluate the efficacy of this kind of treatment, we collect patients with malignant obstructive jaundice receiving this procedure in 2008-2013.

show abstract

“…While malignancy and chemotherapy may have influenced stent migration, Lofts et al [17] found that cancer patients on a chemo-regime of epirubicin, cisplatin, and 5-fluorouracil did not have a significant increase in stent blockage or shortening of stent patency duration. Significant interfraction deformation of the pancreatic head, duodenum, and stomach can occur during pancreatic head irradiation [18], and these interfraction anatomic changes may affect stent migration.…”

Section: Discussionmentioning

confidence: 99%

Endobiliary Stent Position Changes during External-beam Radiotherapy

Chu

Eccles

Brunner

2015

Journal of Medical Imaging and Radiation Sciences

View full text Add to dashboard Cite

PurposeEndobiliary stents can be used as surrogates for pancreatic localization when using cone-beam computed tomography (CBCT) during external-beam radiotherapy (EBRT). This work reports on interfraction stent position changes during EBRT for locally advanced pancreatic cancer (LAPC).Materials and MethodsSix patients with endobiliary stents who underwent EBRT for LAPC were assessed. Measurements from the most superior aspect of the stent (sup stent) and the most inferior aspect of the stent (inf stent) to the most inferior, posterior aspect of the L1 vertebra central spinous process were determined from daily treatment CBCTs and compared with those determined from the planning computed tomography (CT) scan. Changes in stent-L1 measurements were interpreted as changes in relative stent position.ResultsThree patients showed mean interfraction stent position changes of ≥1 cm when treatment measurements were compared with planning measurements. The sup stent for patient A moved to the right (2.66 ± 2.77 cm) and inferiorly (3.0 ± 3.12 cm), and the inf stent moved to the right (1.92 ± 2.02 cm) inferiorly (3.23 ± 3.34 cm) and posteriorly (1.41 ± 1.43 cm). The inf stent for patient B moved superiorly (2.23 ± 0.49 cm) and posteriorly (1.72 ± 0.59 cm). The sup and inf stent for patient F moved inferiorly (0.98 ± 0.35 cm and 1.21 ± 0.38 cm, respectively). The remaining three patients C, D, and E showed interfraction position changes of <1 cm.ConclusionEndobiliary stent migration and deformation were observed in a small subset of patients. Further investigation is required before confirming their use as surrogates for LAPC target localization during image-guided EBRT.

show abstract

Bile duct stents: Is there an increased rate of complications in patients receiving chemotherapy?

Cited by 21 publications

References 12 publications

Efficacy and Safety of Metallic Stents in Patients With Unresectable Pancreatic Cancer Receiving Gemcitabine

Efficacy and Safety of Metallic Stents in Patients With Unresectable Pancreatic Cancer Receiving Gemcitabine

Internal-External Percutaneous Transhepatic Biliary Drainage for Patients with Malignant Obstructive Jaundice

Endobiliary Stent Position Changes during External-beam Radiotherapy

Contact Info

Product

Resources

About